These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 21685475)

  • 1. Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative.
    Biddle A; Liang X; Gammon L; Fazil B; Harper LJ; Emich H; Costea DE; Mackenzie IC
    Cancer Res; 2011 Aug; 71(15):5317-26. PubMed ID: 21685475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
    Geng S; Guo Y; Wang Q; Li L; Wang J
    Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation in 5-FU-induced apoptosis in head and neck cancer stem cells by a combination of CDHP and GSK3β inhibitors.
    Shigeishi H; Biddle A; Gammon L; Rodini CO; Yamasaki M; Seino S; Sugiyama M; Takechi M; Mackenzie IC
    J Oral Pathol Med; 2015 Mar; 44(3):201-7. PubMed ID: 25169655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic Plasticity Determines Cancer Stem Cell Therapeutic Resistance in Oral Squamous Cell Carcinoma.
    Biddle A; Gammon L; Liang X; Costea DE; Mackenzie IC
    EBioMedicine; 2016 Feb; 4():138-45. PubMed ID: 26981578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect.
    Xu Q; Zhang Q; Ishida Y; Hajjar S; Tang X; Shi H; Dang CV; Le AD
    Oncotarget; 2017 Feb; 8(6):9557-9571. PubMed ID: 27926487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
    Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
    Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
    Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
    Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
    Dhumal SN; Choudhari SK; Patankar S; Ghule SS; Jadhav YB; Masne S
    Head Neck Pathol; 2022 Jun; 16(2):453-465. PubMed ID: 34655409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.
    Han M; Liu M; Wang Y; Mo Z; Bi X; Liu Z; Fan Y; Chen X; Wu C
    Mol Cell Biochem; 2012 Apr; 363(1-2):427-36. PubMed ID: 22187223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells.
    Han M; Wang Y; Liu M; Bi X; Bao J; Zeng N; Zhu Z; Mo Z; Wu C; Chen X
    Cancer Sci; 2012 Jun; 103(6):1058-64. PubMed ID: 22435731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo characterization of cancer stem cell subpopulations in oral squamous cell carcinoma.
    Amôr NG; Buzo RF; Ortiz RC; Lopes NM; Saito LM; Mackenzie IC; Rodini CO
    J Oral Pathol Med; 2021 Jan; 50(1):52-59. PubMed ID: 32816395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
    Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
    Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disclosure of a stem cell phenotype in an oral squamous cell carcinoma cell line induced by BMP-4 via an epithelial-mesenchymal transition.
    Qiao B; Johnson NW; Chen X; Li R; Tao Q; Gao J
    Oncol Rep; 2011 Aug; 26(2):455-61. PubMed ID: 21567100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-initiating capacity is independent of epithelial-mesenchymal transition status in breast cancer cell lines.
    Xie G; Ji A; Yuan Q; Jin Z; Yuan Y; Ren C; Guo Z; Yao Q; Yang K; Lin X; Chen L
    Br J Cancer; 2014 May; 110(10):2514-23. PubMed ID: 24755887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphere-forming-like cells (squamospheres) with cancer stem-like cell traits from VX2 rabbit buccal squamous cell carcinoma.
    Chen YK; Huang AH; Lin LM
    Int J Oral Sci; 2014 Dec; 6(4):212-8. PubMed ID: 25012868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma.
    Chen C; Wei Y; Hummel M; Hoffmann TK; Gross M; Kaufmann AM; Albers AE
    PLoS One; 2011 Jan; 6(1):e16466. PubMed ID: 21304586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation.
    Liu L; Salnikov AV; Bauer N; Aleksandrowicz E; Labsch S; Nwaeburu C; Mattern J; Gladkich J; Schemmer P; Werner J; Herr I
    Int J Cancer; 2014 May; 134(10):2489-503. PubMed ID: 24615157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
    Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N
    Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.
    Muraro MG; Mele V; Däster S; Han J; Heberer M; Cesare Spagnoli G; Iezzi G
    Stem Cells Transl Med; 2012 Aug; 1(8):592-603. PubMed ID: 23197865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
    Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
    Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.